Daiwa Securities Group Portfolio holdings
AUM
$27.1B
1-Year Return
23.24%
This Quarter Return
+13.6%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$27.1B
AUM Growth
+$3.44B
(+15%)
Cap. Flow
+$975M
Cap. Flow
% of AUM
3.6%
Top 10 Holdings %
Top 10 Hldgs %
34.67%
Holding
1,358
New
69
Increased
716
Reduced
273
Closed
50
Top Buys
| 1 |
Apple
AAPL
|
$165M |
| 2 |
SBA Communications
SBAC
|
$114M |
| 3 |
Essex Property Trust
ESS
|
$97.6M |
| 4 |
Mid-America Apartment Communities
MAA
|
$87.8M |
| 5 |
Amazon
AMZN
|
$82.2M |
Top Sells
| 1 |
Omega Healthcare
OHI
|
$135M |
| 2 |
American Tower
AMT
|
$118M |
| 3 |
Public Storage
PSA
|
$97M |
| 4 |
UDR
UDR
|
$79.3M |
| 5 |
AvalonBay Communities
AVB
|
$73.5M |
Sector Composition
| 1 | Real Estate | 30.73% |
| 2 | Technology | 27.76% |
| 3 | Communication Services | 10.3% |
| 4 | Consumer Discretionary | 6.75% |
| 5 | Financials | 6.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
BridgeBio Pharma
BBIO
$10.2B
| $29K | ﹤0.01% |
664
+40
| +6% | +$1.75K |
|
|
BPMC
1077
DELISTED
Blueprint Medicines
BPMC
| $29K | ﹤0.01% |
225
+15
| +7% | +$1.93K |
|
1078
Udemy
UDMY
$1B
| $29K | ﹤0.01% |
4,180
-600
| -13% | -$4.16K |
|
1079
iShares MSCI Brazil ETF
EWZ
$5.47B
| $28K | ﹤0.01% |
980
| – | – |
|
1080
Coherent
COHR
$15.2B
| $27K | ﹤0.01% |
300
+100
| +50% | +$9K |
|
1081
Roivant Sciences
ROIV
$8.82B
| $27K | ﹤0.01% |
2,402
-5,353
| -69% | -$60.2K |
|
|
VRNA
1082
Verona Pharma
VRNA
$9.2B
| $25K | ﹤0.01% |
269
| – | – |
|
1083
Madrigal Pharmaceuticals
MDGL
$9.65B
| $23K | ﹤0.01% |
77
+5
| +7% | +$1.49K |
|
1084
Jazz Pharmaceuticals
JAZZ
$7.86B
| $23K | ﹤0.01% |
215
-1,785
| -89% | -$191K |
|
1085
Chesapeake Utilities
CPK
$2.96B
| $21K | ﹤0.01% |
+171
| New | +$21K |
|
1086
Guardant Health
GH
$7.5B
| $21K | ﹤0.01% |
408
| – | – |
|
1087
Axsome Therapeutics
AXSM
$6.25B
| $18K | ﹤0.01% |
177
+17
| +11% | +$1.73K |
|
1088
iShares MSCI Mexico ETF
EWW
$1.84B
| $18K | ﹤0.01% |
300
| – | – |
|
1089
Nuvalent
NUVL
$5.83B
| $18K | ﹤0.01% |
239
+22
| +10% | +$1.66K |
|
1090
Vanguard Short-Term Treasury ETF
VGSH
$22.9B
| $18K | ﹤0.01% |
+298
| New | +$18K |
|
1091
Alkermes
ALKS
$4.94B
| $17K | ﹤0.01% |
593
+59
| +11% | +$1.69K |
|
1092
ADMA Biologics
ADMA
$4.03B
| $16K | ﹤0.01% |
858
+78
| +10% | +$1.46K |
|
1093
Ciena
CIEN
$16.5B
| $16K | ﹤0.01% |
200
-200
| -50% | -$16K |
|
1094
Akero Therapeutics
AKRO
$3.58B
| $15K | ﹤0.01% |
272
| – | – |
|
1095
Vanguard Emerging Markets Government Bond ETF
VWOB
$4.58B
| $15K | ﹤0.01% |
228
+210
| +1,167% | +$13.8K |
|
1096
Cytokinetics
CYTK
$6.34B
| $14K | ﹤0.01% |
429
+40
| +10% | +$1.31K |
|
1097
Krystal Biotech
KRYS
$4.35B
| $14K | ﹤0.01% |
104
+9
| +9% | +$1.21K |
|
1098
Rhythm Pharmaceuticals
RYTM
$6.78B
| $14K | ﹤0.01% |
229
+26
| +13% | +$1.59K |
|
1099
Acadia Pharmaceuticals
ACAD
$4.26B
| $13K | ﹤0.01% |
602
+53
| +10% | +$1.15K |
|
1100
Arcellx
ACLX
$4.03B
| $13K | ﹤0.01% |
198
+20
| +11% | +$1.31K |
|